OncoC4

OncoC4

MD - Rockville
Biotechnology

Focus: Antibodies, Immunotherapies

OncoC4 is a life sciences company focused on Antibodies, Immunotherapies.

OncologyCancer ImmunotherapyUnknown
Open Jobs
4

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT06219499Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841
Phase 1
AI-061
Melanoma
Phase 1
Clinical Trials (1)
NCT05858736Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
Phase 1
Phase 1
Clinical Trials (1)
NCT07408258Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
Phase 1
Phase 1
Clinical Trials (1)
NCT06352359Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
Phase 1
Clinical Trials (1)
NCT04140526Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
Phase 1/2
Clinical Trials (1)
NCT05682443ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06635785Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Phase 1/2
Phase 2
Phase 3
Clinical Trials (1)
NCT05671510ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Phase 3

Open Jobs (4)

Interview Prep Quick Facts
Portfolio: 8 clinical trials
Open Roles: 4 active jobs